Eight selected Gordonibacter short rods appear in six groupings: four singles and two touching division pairs, with three restrained conical apex endings.
Genus representative reconstruction Editorially reviewed

Type-species-anchored Gordonibacter short-rod and coccobacillary forms, shown as eight bodies in four single and two paired groupings, with exactly three restrained conical-apex treatments. This genus-level reconstruction is representative, non-diagnostic, and not a universal genus form or a micrograph.

WikiBiome / Microbiome MedicineCurrent-genus-taxonomy-, type-species-, primary-description-, and ultrastructure-informed representative reconstruction
Scientific media record1 verified identifier
Subject
Gordonibactertaxon · genus
Review
Editorial review completeIdentifiers authority-verified · Accessibility validated · · gordonibacter|gordonibacter-morphology-v1.webp
Digital source
Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
License
CC BY-SA 4.0Created

Gordonibacter is a genus of Gram-positive, strictly anaerobic gut bacteria within the phylum Actinobacteria. It is recognized as a key participant in polyphenol metabolism, producing bioactive metabolites including equol (from dietary isoflavones) and urolithins (from ellagic acid and ellagitannins).

These metabolites have anti-inflammatory and estrogenic properties, making Gordonibacter functionally relevant to estrogen-dependent and neuroinflammatory conditions.

Fecal metabolomic studies in endometriosis mouse models show altered polyphenol metabolite profiles consistent with Gordonibacter depletion ([1]Ni 2020 — Fecal Metabolomics and Gut Microbiota Correlation in Endometriosis MiceZhexin Ni, Shuai Sun, Yanli Bi et al. · 2020Open reference 1), while microbial metabolite analyses in multiple sclerosis identify reduced urolithin-producing taxa as part of the broader dysbiotic pattern ([2]Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and TreatmentEduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto · 2022Open reference 2).

Evidence map1 cited passagesInspect provenance +
01
Introduction

These metabolites have anti-inflammatory and estrogenic properties, making Gordonibacter functionally relevant to estrogen-dependent and neuroinflammatory conditions. Fecal metabolomic studies in endometriosis mouse models show altered polyphenol metabolite profiles consistent with Gordonibacter depletion (), while microbial metabolite analyses in multiple s

Contents1. Cross-References

Cross-References#

  • equol—bioactive metabolite produced by Gordonibacter
  • Polyphenols—dietary substrates for Gordonibacter metabolism
  • Endometriosis—condition where Gordonibacter is depleted
  • Multiple Sclerosis—neuroinflammatory condition with altered polyphenol metabolism
  • Estrobolome—functional overlap with estrogen-metabolizing gut taxa
Generated evidence record

References 6

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    Zhexin Ni, Shuai Sun, Yanli Bi et al. (2020). Ni 2020 — Fecal Metabolomics and Gut Microbiota Correlation in Endometriosis Mice. American Journal of Reproductive Immunology.

  2. 2

    Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto (2022). Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment. Frontiers in Neuroscience.

  3. 3

    Keer Zhou, Ancha Baranova, Hongbao Cao et al. (2024). Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian Randomization. Schizophrenia (Nature Partner Journal).

  4. 4

    Bucciero C, Croce A, Castellano G et al. (2026). The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms. Molecular Neurobiology.

  5. 5

    Thirion F, Sellebjerg F, Fan Y et al. (2023). The Gut Microbiota in Multiple Sclerosis Varies with Disease Activity. Genome Medicine.

  6. 6

    Stefan Heinzel, Sepehr Rahnemaiard, Daniela Berg (2021). Heinzel 2021 -- Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson's Patients. Nutrients.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

1 events
  1. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +41 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

6 references · 2 backlinks · 4 indexed topics